Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Angiotech lowers guidance

Angiotech (TSX:ANP; ANPI) fell C$2.53 (34%) to C$4.82 on Friday after the company lowered

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE